Two and Three-Dimensional Echocardiography in Primary Mitral Regurgitation: Practical Hints to Optimize the Surgical Planning
Maria Concetta Pastore1,2* 
Giulia Elena Mandoli1 
Anna Sannino3,4 Aleksander Dokollari5 Gianluigi Bisleri5 Flavio D'Ascenzi1 Luna Cavigli1 Annalisa Pasquini6 Matteo Lisi1,7 Nicolò Ghionzoli1 Ciro Santoro3 Marcelo Haertel Miglioranza8 Marta Focardi1 Giuseppe Patti2 Serafina Valente1 Sergio Mondillo1 
Matteo Cameli1- 1Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy
- 2Maggiore della Carità Hospital, University of Eastern Piedmont, Novara, Italy
- 3Department of Advanced Biomedical Science, Federico II University Hospital Naples, Naples, Italy
- 4Baylor Research Institute, The Heart Hospital Baylor Plano, Plano, TX, United States
- 5Cardiac Surgery, St. Michael Hospital, Toronto, ON, Canada
- 6Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università Cattolica del Sacro Cuore, Rome, Italy
- 7Division of Cardiology, Department of Cardiovascular Diseases – Azienda Unità Sanitaria Locale (AUSL) Romagna, “Santa Maria delle Croci” Hospital, Ravenna, Italy
- 8Cardiology Institute of Rio Grande Do Sul, University Foundation of Cardiology, Porto Alegre, Brazil
Primary mitral regurgitation (MR) is the second most common valvular disease, characterized by a high burden in terms of quality of life, morbidity, and mortality. Surgical treatment is considered the best therapeutic strategy for patients with severe MR, especially if they are symptomatic. However, pre-operative echocardiographic evaluation is an essential step not only for surgical candidate selection but also to avoid post-operative complications. Therefore, a strong collaboration between cardiologists and cardiac surgeons is fundamental in this setting. A meticulous pre-operative echocardiographic exam, both with transthoracic or transesophageal echocardiography, followed by a precise report containing anatomical information and parameters should always be performed to optimize surgical planning. Moreover, intraoperative transesophageal evaluation is often required by cardiac surgeons as it may offer additive important information with different hemodynamic conditions. Three-dimensional echocardiography has recently gained higher consideration and availability for the evaluation of MR, providing more insights into mitral valve geometry and MR mechanism. This review paper aims to realize a practical overview on the main use of basic and advanced echocardiography in MR surgical planning and to provide a precise checklist with reference parameters to follow when performing pre-operative echocardiographic exam, in order to aid cardiologists to provide a complete echocardiographic evaluation for MR operation planning from clinical and surgical point-of-view.
Introduction
Mitral regurgitation (MR) is the second most common valvular heart disease (after aortic stenosis), and the second most frequent indications for cardiac surgery. Primary MR consist of a mitral apparatus anatomic disease, with the most frequent etiology being degenerative.
The current European Society of Cardiology (ESC) guidelines recommend surgical treatment for MR in case of symptomatic patients with severe chronic primary MR, or asymptomatic with left ventricular (LV) dysfunction [LV enlargement or reduced ejection fraction (EF)], taking also into account the presence enlarged left atrium and/or of atrial fibrillation (AF) due to the risk of embolic events (47) or pulmonary hypertension (PH) (1).
American guidelines recommend mitral valve (MV) surgery for symptomatic patients with chronic severe primary MR or asymptomatic patients with LV dysfunction (assessed with LV EF 30–60% and/or LV end-systolic diameter >40 mm) (2).
However, when the patient has been referred for surgical treatment of MR, a meticulous planning of the intervention is the cornerstone for its success. At this stage, a close collaboration between the cardiologist and the cardiac surgeon is paramount to facilitate the surgical procedure and to ensure patient the best management.
Transthoracic and transesophageal echocardiography play a key role for the pre-operatory evaluation of MR patients. Beyond the conventional indices used for the assessment and quantification of MR (3), there are additional anatomic and functional measures of mitral valve apparatus which are highly required from cardiac surgeons before intervention. Therefore, each cardiac imager should be trained on the elements and parameters to focus on when evaluating a MR patient waiting for surgery, in order to operate a complete echocardiographic assessment and provide all the required information for this multidisciplinary approach. The present review aims to describe the pivotal elements for the correct planning of MR surgery analyzing the echocardiographer and cardiac surgeons' points of view, in order to assist clinicians in the use of traditional and newest echocardiographic techniques preoperative MR evaluation.
2D Echocardiography: Focus on Mitral Valve
The first task of the echocardiographer is to provide better insight on mitral valve (MV) anatomy, which can be divided into 6 scallops: 3 constituting the anterior leaflet, and 3 the posterior leaflet. Imagers' attention should be focused on different anatomic point depending on the various mechanisms of MR. The mostly known classification of primary MR etiology by Carpentier includes (4):
• Type 1-normal leaflet motion (leaflet perforation or cleft),
• Type II: excessive leaflet motion (leaflet prolapse),
• Type III-restricted leaflet motion (rheumatic MR, calcification, drug-induced MR)
Arguably, these primary anomalies of mitral valve anatomy and function and their different complexity will require different approaches for surgical treatment (5) (that would be further explained later). Accordingly, there will be some different paramount pre-operative information that could be provided by echocardiography [(6); Table 1].
Table 1. Preferred surgical treatment and necessary echocardiographic information according to Carpentiers' classification of primary mitral regurgitation, with representative cases for each type by transoesophageal echocardiography.
Beyond these essential parameters, the following MV anatomic measures are considered useful for guiding surgical techniques in each type of MR etiology (Supplementary Figure 1):
Annulus area
• Chordae and leaflet length
• Presence of calcification
• Anterior leaflet-IVS distance
• Mitral-aortic angle
• Interventricular septum (IVS) thickness and presence of subaortic spur
• Left ventricular outflow tract measure.
Bidimensional Echocardiography: Overview on Cardiac Function
Left Heart
Transthoracic echocardiography (TTE) is the gold standard technique to assess LV dimension and function: not only LV dysfunction could be the cause of a secondary MR, but could be the consequence of primary MR, due to a chronic volume overload. For the quantification of LV volumes and function, both 2D (Simpson method) and 3D echocardiography are recommended (3).
It is known that LA enlargement is a common consequence of chronic MR. In fact, LA dimensions are considered in MR severity assessment since patients with smaller LA are less likely to have severe MR. LA volume should be measured by 2D echocardiography, with biplane Simpson disks method at end-systole (7).
Recent evidence has shown how the use of advanced deformation imaging could provide early identification of left heart impairment in chronic MR and additive prognostic information. This could be easily and reliably assessed by speckle tracking echocardiography (8), with an offline analysis of 2D echocardiographic indices providing information on LV and LA longitudinal deformation all over the cardiac cycle, quantified as LV and LA longitudinal strain (this could be divided into LA reservoir; conduit and contractile strain based on LA deformation phases) (Figure 1). LA strain has been shown to describe LA worsening function parallel to MR severity in patients with asymptomatic MR (9), moreover, it correlates with invasively-assessed myocardial fibrosis caused by severe MR in patients with MV prolapse (10) and is a strong predictor of outcome not only in patients with severe MR (11, 12), but also in patients with moderate MR (13).
Figure 1. Left atrial strain in a healthy subject (Left) and in a patient with severe mitral regurgitation (Right). PACS, peak atrial contraction strain; PALS, peak atrial longitudinal (reservoir) strain.
In a recent study by Kim et al., preoperative LV global longitudinal strain (GLS) showed a better prediction of cardiac outcome after surgery in 506 patients with severe MR compared to conventional parameters (LV dysfunction, AF, type of surgery) (14). Furthermore, LV GLS was an independent predictor of exercise capacity in 660 asymptomatic patients with >3 primary MR, preserved LV EF and non-dilated LV.
Right Heart
As shown in Table 1, the assessment of tricuspid anatomic properties and of coexisting tricuspid regurgitation (TR) is of outmost importance in pre-surgical evaluation of MR in order to assess the necessity of concomitant tricuspid annuloplasty during MV intervention. In fact, it has been demonstrated (15, 16) that the pre-operative tricuspid annulus measurement predicts residual functional TR post- MV surgery. Current recommendations for tricuspid valve surgery state that:
• Surgery is recommended in patients with severe TR who should undergo left-sided valve surgery regardless of symptoms (Class I),
• Surgery should be considered (Class IIa) in patients with mild/moderate secondary TR and/or significant annular dilatation (≥40 mm or 21 mm/m2; Class IIa) (1).
Moreover, a conscious assessment of RV dimensions and function would be important before MV surgery, since RV function could be considerably affected by cardiac surgery (15). On the other hand, pre-existing RV structural and functional damage could represent a higher risk of worse outcome after intervention (16) even if more evidence is required in this field. RV enlargement could be assessed by linear dimensions: basal diameter >42 mm and/or mid-cavity diameter >33 mm indicate RV dilatation; and RV areas (both end-diastolic and end-systolic area), that could also be used to calculate an index of RV function, RV fractional area change as (end-diastolic – end-systolic area)/end diastolic area. Also, M-mode tricuspid annular plane systolic excursion (<17 mm) and tricuspid annular systolic tissue Doppler velocity (<11 cm/s) are recommended as markers of RV dysfunction. STE could also be useful in these cases, in fact, RV strain has demonstrated its superiority over basic echocardiographic indices for the assessment of RV function, since, unlike the previous indices which analyze the annular portion of RV, it provides a more complete assessment of RV global longitudinal function and has also shown to correlate with RV pressures and outcome in patients with heart failure (17).
When a Transesophageal Approach Is Necessary
Even though TTE could provide enough diagnostic and pre-operative information for patients with severe MR, multiplane transesophageal echocardiogram (TEE) is currently required in almost all cases of MR before surgery, especially in presence of suboptimal TTE image quality (7), in absence of absolute contraindications (Table 2). As TTE, TEE may assess all the required parameters, listed in in Table 3, using 4-chamber, inter-commissural, and long-axis views, with higher sensitivity than TTE alone, resulting in deeper insights into the precise mechanisms of MV disease and the precise definition of the site responsible for MV dysfunction [(20); Supplementary Figure 1].
Table 2. Absolute and relative contraindications to perform transoesophageal echocardiography [modified from (18)].
Table 3. Pre-operative echocardiographic checklist for planning mitral regurgitation surgery (6, 18, 19).
Particularly, TEE would be useful to assess the feasibility of durable repair (21), and the signs of higher probability of treatment failure:
1. Anatomic characteristics (22):
- Large central regurgitant jet
- Severe annular dilatation (> 50 mm)
- Involvement of ≥3 scallops
- Extensive valve calcification
2. Risk factors for post-operative SAM (with hemodynamic instability) (7, 18, 19)
- Coaptation-septum distance
- Mitral-aortic angle
- Long anterior leaflet (AL height at A2, middle scallop, to identify appropriate ring size)
- Length of PLs and ratio between anterior and PL length
- Non-dilated and hyper-dynamic LV
3. For Type 3 Carpentier severe regurgitant jet associated with (18):
- MV annulus diameter ≥37 mm
- Coaptation distance >1 cm
- Systolic tenting area >2.5 cm2
- PL angle> 45°
- Presence of asymmetric tethering
Moreover, in the last years TEE has affirmed its pivotal role in intraoperative evaluation, in order to obtain a real-time assessment of the results of MV repair/replacement (e.g., residual regurgitant jet; presence of SAM), and improve surgical outcome.
However, TEE is not always promptly available, is an invasive method (sometimes requiring sedation), and has several absolute and relative contraindications (Table 2), therefore sometimes TTE should be preferred.
Three-Dimensional Echocardiography
Role in Pre-procedural Planning
The role of 3D echocardiography in the setting of MV surgery for primary MR can be summarized in 3 main objectives:
1. Assess MR severity by 3D vena contracta area (VCA) and/or 3D reconstruction modeling
2. Define the “reparability” of the MV
3. Sizing of the annuloplasty band or ring
In cases where 2D assessment of MR severity is doubtful, 3D echocardiography can help obtaining an accurate assessment of the severity of the regurgitation.
The introduction of 3D echocardiography into clinical practice has provided direct measurement of VCA. This could be obtained by multiplanar reconstruction tools to orient orthogonal imaging planes (x and y) through the long axis of the MR jet, with the z plane adjusted perpendicularly through the narrowest cross-sectional area of the vena contracta. VCA is then measured by manual planimetry of the color Doppler signal (Supplementary Figure 2). In case of MR characterized by multiple jets, the imaging plane should be oriented through each jet separately for tracing. A value of 3D VCA >0.4 cm2 denotes severe MR (23).
The reparability of a MV depends on two important considerations:
a. The presence of extensive leaflet or annular calcification;
b. The presence of a complex degenerative anatomy e.g., anterior MV leaflet prolapse, bileaflet prolapse, or Barlow disease (24).
Significant annular calcification hampers the possibility and/or the durability of the repair. On the other hand, the presence of complex degenerative anatomy in the hands of low experienced surgeons may lead to suboptimal repair or MV replacement and also affects the durability of repair. The presence of clefts or indentations is as well very important as it contributes to the complexity of the disease and thus of the intervention. 3D Echocardiography and in particular 3D TEE are extremely helpful for the surgeon to identify such complex anatomies as well as to investigate the presence of indentations and clefts in the MV leaflets [(22, 24–27); Figure 2].
Figure 2. Degenerative MR due to P2 flail in the context of a complex anatomy. (A) 2D images and relative 3D (on top) showing P2 leaflet flail form the long-axis view and commissural view. (B) Magnification of the 3D short-axis on the MV (surgeons' view), where the P2 flail is easily appreciated (red arrow), together with a deep indentation (cleft- yellow arrow) between P2 and P3, which justify the presence of multiple jets. (C) Color Doppler image of the long-axis view, showing at least 2 regurgitant MR jets.
Secondly, but not less important, quantitative 3D TEE allows to measure A2 height, inter-trigonal distance, and total annular perimeter size, which are useful to determine the size of the annuloplasty ring or band. In fact, A2 height and inter-trigonal distance are most commonly evaluated by surgeons during the operation. Despite the fact that 3D TEE does not replace the final sizing done by the surgeon in the OR, it does represent a useful guide as this information, if available before the procedure, could be useful for the surgeon to make comparisons to intraoperative sizing, which is done differently by different surgeons (28). The other quantitative data very helpful to the surgeon is the P2 height; if this is >20 mm, the reduction of this measure becomes essential to prevent post-operative SAM of the MV and LVOT obstruction [(29); Figure 3].
Figure 3. Example of MV model, used to estimate inter-trigonal distance (T1-T2 distance in the top left panel; orange arrow) and thus MV ring size.
3D TEE may also have a pivotal role to accurately describing all MV lesions (e.g., clefts, commissural abnormalities, and tethering of the anterior MV leaflet) which are essential when planning chordal implantation, to ensure appropriate patient selection.
Role in the Operating Room
Procedural guidance for surgical MV repair is developed around a comprehensive baseline intraoperative TEE to establish (or confirm) findings in the pre-preprocedural TEE and, above all, the anatomic basis of the MR. Moreover, assessment of LV and RV function, the evaluation of the degree of TR and measurement of the tricuspid annulus specifically are essential. Post-operative TEE evaluation includes locating and detecting intracardiac air when coming off cardiopulmonary bypass and assessment of the integrity of the MV repair. If residual MR is present, its severity and origin must be investigated. A post-procedural evaluation of the LV and RV function is also essential to ensure that there has not been a significant change from baseline.
Conclusions
The collaboration between cardiologist and cardiac surgeon is paramount for mitral regurgitation surgical planning and during intervention. Echocardiography plays a pivotal role in the evaluation of mitral regurgitation, and the use of advanced techniques like transesophageal, speckle tracking and 3D echocardiography allows a better definition of anatomical and functional measures in order to optimize surgical planning. This review offers an algorithm to follow (Figure 4), a graphical guide for measurements and a checklist to fulfill to help clinicians in performing echocardiography for preoperative assessment of patients undergoing mitral valve surgery.
Figure 4. Algorithm to follow for preoperative evaluation of mitral regurgitation in order to promote the collaboration between cardiologist and cardiac surgeon and optimize surgical planning. LA, left atrial; LV, left ventricular; MV, mitral valve; TEE, transesophageal echocardiography; VCA, vena contracta area.
Author Contributions
MP, GM, AS, AD, NG, GB, and AP performed the data search and drafted the manuscript. MC, FD'A, LC, ML, MM, CS, MF, GP, SV, and SM critically revised the draft. All Authors contributed to the conception of this work and approved the final version of the manuscript.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcvm.2021.706165/full#supplementary-material
Supplementary Figure 1. Transthoracic and transoesophageal echocardiographic mitral valve anatomic parameters required for the surgical planning of mitral regurgitation. EDD, end-diastolic diameters; IVS, interventricular septum distance; LVOT; left ventricular outflow tract; MV, mitral valve.
Supplementary Figure 2. Example of Vena Contracta Area (VCA) estimation from multi-planar reconstruction of MV in a 3D color Doppler dataset. VCA is obtained by first aligning the blu plane with the vena contracta and then aligning the red and green planes with the jet direction. VCA area is then manually traced in the short axis view (blu plane).
References
1. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. (2017) 38:2739–91. doi: 10.1093/eurheartj/ehx391
2. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. (2017) 135:e1159–95. doi: 10.1161/CIR.0000000000000503
3. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. (2015) 16:233–70. doi: 10.1093/ehjci/jev014
4. Carpentier A, Chauvaud S, Fabiani JN, Deloche A, Relland J, Lessana A, et al. Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg. (1980) 79:338–48. doi: 10.1016/S0022-5223(19)37942-5
5. Yazdchi F, Kaneko T, Tang GHL. Surgical versus percutaneous approaches for degenerative mitral valve repair: a review. Struct. Heart. (2019) 3:176–84. doi: 10.1080/24748706.2019.1596337
6. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. (2013) 14:611–44. doi: 10.1093/ehjci/jet105
7. Cimino S, Guarracino F, Valenti V, Frati G, Sciarretta S, Miraldi F, et al. Echocardiography and correction of mitral regurgitation: an unbreakable link. Cardiology. (2020). 145:110–20. doi: 10.1159/000504248
8. Pastore MC, De Carli G, Mandoli GE, D'Ascenzi F, Focardi M, Contorni F, et al. The prognostic role of speckle tracking echocardiography in clinical practice: evidence and reference values from the literature. Heart Fail Rev. (2020). doi: 10.1007/s10741-020-09945-9. [Epub ahead of print].
9. Pastore MC, Mandoli GE, Dokollari A, Bisleri G, D'Ascenzi F, Santoro C, et al. Speckle tracking echocardiography in primary mitral regurgitation: should we reconsider the time for intervention? Heart Fail Rev. (2021). doi: 10.1007/s10741-021-10100-1. [Epub ahead of print].
10. Cameli M, Lisi M, Righini FM, Massoni A, Natali BM, Focardi M, et al. Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol. (2013) 111:595–601. doi: 10.1016/j.amjcard.2012.10.049
11. Yang LT, Liu YW, Shih JY, Li YH, Tsai LM, Luo CY, et al. Predictive value of left atrial deformation on prognosis in severe primary mitral regurgitation. J Am Soc Echocardiogr. (2015) 28:1309–17.e4. doi: 10.1016/j.echo.2015.07.004
12. Debonnaire P, Leong DP, Witkowski TG, Al Amri I, Joyce E, Katsanos S, et al. Left atrial function by two-dimensional speckle-tracking echocardiography in patients with severe organic mitral regurgitation: association with guidelines-based surgical indication and postoperative (long-term) survival. J Am Soc Echocardiogr. (2013) 26:1053–62. doi: 10.1016/j.echo.2013.05.019
13. Cameli M, Pastore MC, Righini FM, Mandoli GE, D'Ascenzi F, Lisi M, et al. Prognostic value of left atrial strain in patients with moderate asymptomatic mitral regurgitation. Int J Cardiovasc Imaging. (2019) 35:1597–604. doi: 10.1007/s10554-019-01598-6
14. Kim HM, Cho GY, Hwang IC, Choi HM, Park JB, Yoon YE, et al. Myocardial strain in prediction of outcomes after surgery for severe mitral regurgitation. JACC Cardiovasc Imaging. (2018) 11:1235–44. doi: 10.1016/j.jcmg.2018.03.016
15. Mandoli GE, Cameli M, Novo G, Agricola E, Righini FM, Santoro C, et al. Right ventricular function after cardiac surgery: the diagnostic and prognostic role of echocardiography. Heart Fail Rev. (2019) 24:625–35. doi: 10.1007/s10741-019-09785-2
16. Ye Y, Desai R, Vargas Abello LM, Rajeswaran J, Klein AL, Blackstone EH, et al. Effects of right ventricular morphology and function on outcomes of patients with degenerative mitral valve disease. J Thorac Cardiovasc Surg. (2014) 148:2012–20.e8. doi: 10.1016/j.jtcvs.2014.02.082
17. Pastore MC, Mandoli GE, Aboumarie HS, Santoro C, Bandera F, D'Andrea A, et al. Basic and advanced echocardiography in advanced heart failure: an overview. Heart Fail Rev. (2019) 25:937–48. doi: 10.1007/s10741-019-09865-3
18. Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. (2013) 26:921–64. doi: 10.1016/j.echo.2013.07.009
19. Garbi M, Monaghan MJ. Quantitative mitral valve anatomy and pathology. Echo Res Pract. (2015) 2:R63–72. doi: 10.1530/ERP-15-0008
20. Wunderlich NC, Beigel R, Ho SY, Nietlispach F, Cheng R, Agricola E, et al. Imaging for mitral interventions: methods and efficacy. JACC Cardiovasc Imaging. (2018) 11:872–901. doi: 10.1016/j.jcmg.2018.02.024
21. El Sabbagh A, Reddy YNV, Nishimura RA. Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions. JACC Cardiovasc Imaging. (2018) 11:628–43. doi: 10.1016/j.jcmg.2018.01.009
22. Adams DH, Anyanwu AC. Revisiting the long-term goals of degenerative mitral valve repair: beyond eliminating mitral regurgitation. J Am Coll Cardiol. (2019) 74:1054–6. doi: 10.1016/j.jacc.2019.07.023
23. Zeng X, Levine RA, Hua L, Morris EL, Kang Y, Flaherty M, et al. Diagnostic value of vena contracta area in the quantification of mitral regurgitation severity by color Doppler 3D echocardiography. Circ Cardiovasc Imaging. (2011) 4:506–13. doi: 10.1161/CIRCIMAGING.110.961649
24. Anyanwu AC, Itagaki S, Chikwe J, El-Eshmawi A, Adams DH. A complexity scoring system for degenerative mitral valve repair. J Thorac Cardiovasc Surg. (2016) 151:1661–70. doi: 10.1016/j.jtcvs.2016.01.033
25. David TE, Armstrong S, McCrindle BW, Manlhiot C. Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation. (2013) 127:1485–92. doi: 10.1161/CIRCULATIONAHA.112.000699
26. Nishida H, Fukui T, Kasegawa H, Kin H, Yamazaki M, Takanashi S. Causes of repair failure for degenerative mitral valve disease and reoperation outcomes. Eur J Cardiothorac Surg. (2018) 53:1244–50. doi: 10.1093/ejcts/ezx468
27. David TE, David CM, Tsang W, Lafreniere-Roula M, Manlhiot C. Long-term results of mitral valve repair for regurgitation due to leaflet prolapse. J Am Coll Cardiol. (2019) 74:1044–53. doi: 10.1016/j.jacc.2019.06.052
28. Calleja A, Poulin F, Woo A, Meineri M, Jedrzkiewicz S, Vannan MA, et al. Quantitative modeling of the mitral valve by three-dimensional transesophageal echocardiography in patients undergoing mitral valve repair: correlation with intraoperative surgical technique. J Am Soc Echocardiogr. (2015) 28:1083–92. doi: 10.1016/j.echo.2015.04.019
Keywords: mitral regurgitation, echocardiography, three-dimensional, surgery, planning
Citation: Pastore MC, Mandoli GE, Sannino A, Dokollari A, Bisleri G, D'Ascenzi F, Cavigli L, Pasquini A, Lisi M, Ghionzoli N, Santoro C, Miglioranza MH, Focardi M, Patti G, Valente S, Mondillo S and Cameli M (2021) Two and Three-Dimensional Echocardiography in Primary Mitral Regurgitation: Practical Hints to Optimize the Surgical Planning. Front. Cardiovasc. Med. 8:706165. doi: 10.3389/fcvm.2021.706165
Received: 06 May 2021; Accepted: 04 June 2021;
Published: 08 July 2021.
Edited by:
Carla Sousa, São João University Hospital Center, PortugalReviewed by:
Jolanda Sabatino, Royal Brompton Hospital, United KingdomNuno Moreno, Hospital Pedro Hispano, Portugal
Helena Nascimento, Centro Hospitalar de Entre o Douro e Vouga E.P.E., Portugal
Copyright © 2021 Pastore, Mandoli, Sannino, Dokollari, Bisleri, D'Ascenzi, Cavigli, Pasquini, Lisi, Ghionzoli, Santoro, Miglioranza, Focardi, Patti, Valente, Mondillo and Cameli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Maria Concetta Pastore, pastore2411@gmail.com